Malaria is endemic in Chad, with a prevalence of around 41 percent in 2017. The World Health Organization recommends seasonal malaria chemoprevention (SMC) for children 3–59 months in areas of highly seasonal transmission across the Sahel. Routine household surveys conducted to evaluate coverage and quality of SMC delivery in Chad found that sulfadoxine-pyrimethamine and amodiaquine administration to children over 59 months appears to be common.
Country: ChadKeywords: Capacity development | Community delivery | Child and maternal health | Policy development | Use of evidence | Malaria | Maternal, neonatal and child health | Preventive treatments | Seasonal malaria chemoprevention | SDG3
« Back to Publications